Mendelian Randomization Analyses Indicate a Causal Association Between Sodium-Glucose Cotransporter-1 Inhibition and...

Area of Science:

• Genetics and Molecular Biology
• Mitochondrial Function
• Metabolic Pathways

Background:

• The precise role of sodium-glucose cotransporter-1 (SGLT1) in mitochondrial biology is not well understood.
• Investigating the link between SGLT1 activity and mitochondrial function is crucial for understanding cellular metabolism.
• Mendelian randomization (MR) offers a robust approach to explore causal relationships between genetic predispositions and biological functions.

Purpose of the Study:

• To investigate the causal association between SGLT1 inhibition and mitochondrial biology function.
• To utilize Mendelian randomization (MR) analysis to establish a genetic link between SGLT1 and mitochondrial processes.
• To identify specific mitochondrial components affected by SGLT1 inhibition.

Main Methods:

• A two-sample Mendelian randomization (MR) study design was employed.
• Genetic variants associated with SGLT1 inhibition (via SLC5A1 gene expression and HbA1c) were used as instrumental variables.
• Inverse variance weighted (IVW) algorithm was the primary analytical method, supplemented by weighted median and MR-Egger methods for sensitivity analysis.

Main Results:

• Genetically predicted SGLT1 inhibition showed a positive association with the upregulation of mitochondrial components, including Serine tRNA ligase and NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8.
• Conversely, SGLT1 inhibition was negatively associated with the downregulation of mitochondrial components such as Glutaredoxin-2, Pyruvate carboxylase, and Mitochondrial glutamate carrier 2 in the European population.
• These findings suggest a significant, bidirectional impact of SGLT1 inhibition on various mitochondrial proteins.

Conclusions:

• This study provides the first genetic evidence causally linking SGLT1 inhibition to a diverse array of mitochondrial biology processes in the European population.
• SGLT1 inhibition influences mitochondrial function through the regulation of specific proteins, including NDUFB8, GRX2, and PC.
• Further basic and clinical research is warranted to fully elucidate the underlying mechanisms of this causal relationship and its therapeutic implications.